Publicacions
-
Alonso-Saladrigues A, Esperanza-Cebollada E, Vicente-Garces C, Pérez-Jaume S, Sánchez-Sierra N, Richarte M, Català-Temprano A, Crespo-Carrasco A, Dapena JL, Cuatrecasas E, Faura A, Ruiz-Cobo MA, Arqués L, Conde N, Andreu S, Isola I, Jordán-García I, Garcia-Rey E, Llanos C, Marsal-Ricoma J, Celis-Passini V, Camós-Guijosa M, Torrebadell-Burriel M, Vega-García N and Rives-Solà S.
Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy
BONE MARROW TRANSPLANTATION . : .
-
Santa-María López V, Felip-Badia A, Marina Caballero Bellón, Sanchez-Sierra N, Castañeda-Heredia A, Garraus-Oneca M, Gorostegui M, Simão-Rafael M, Muñoz JP, Pérez-Somarriba M, Mañe S, Planells MC, Pérez-Jaume S and Mora J.
Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
PEDIATRIC BLOOD & CANCER . 73(4): .
-
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano-Escuder P, Pérez-Jaume S, Garcia-López M, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma
CANCER RESEARCH . 85(22): 4485-4503. Nº de cites: 1
-
Ana Carolina Izurieta Pacheco, Noyd DH, Challinor J, Rossell N, Olarte-Sierra MF, Blanco DB, Zubieta M, George NB, Pérez-Jaume S, Felip-Badia A, Trigoso V, Loggetto P, Gonzalez V, Frias C, Rincon S, Ortiz R, de Aparicio SF and Ponce LV.
Childhood Cancer Survivors in Latin America: Insights Into Health Outcomes and Information Needs
PEDIATRIC BLOOD & CANCER . 72(9): . Nº de cites: 2
-
Pérez-Jaume S and Carrasco, Josep L..
Comparison of optimum threshold estimators in the binormal setting
JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION . 95(5): 1058-1070.
-
Esther Martínez García, López de San Roman Fernández C, Nishishinya Aquino MB, Pérez-Jaume S, Fernández-Jané C, Cruz-Martínez O and Morales-La Madrid A.
Patient Acceptability of the First Integrative Pediatric Oncology Unit in Spain-The Pediatric Cancer Center Barcelona Experience: A Retrospective Study
Cancers . 17(2): . Nº de cites: 2
-
Cristina Larrosa Espinosa, Mico S, Ramos M, Pérez-Jaume S, Sánchez M, Castañeda-Heredia A, Garraus-Oneca M and Mora J.
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes
PEDIATRIC BLOOD & CANCER . 71(10): . Nº de cites: 1
-
Mora J, Climent A, Roldan-Molina M, Flores MC, Varo A, Pérez-Jaume S, Jou-Munoz C, Celma MS, Lazaro JJ, Cheung I, Castañeda-Heredia A, Gorostegui M, Rodriguez E, Chamorro S, Muñoz JP and Cheung NK.
Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects
Frontiers in Oncology . 14: 1380917-1380917.
-
Gorostegui M, Muñoz JP, Pérez-Jaume S, Simao-Rafael M, Cristina Larrosa Espinosa, Garraus-Oneca M, Salvador-Marcos N, Lavarino C, Krauel L, Mañe S, Castañeda-Heredia A and Mora J.
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy
Cancers . 16(9): . Nº de cites: 3
-
Fresno Cañada C, Gispets Parcerisas J, Del Prado-Sanchez C, Puigventós E, Pérez-Jaume S, Salvador-Hernandez H, Llorca Cardeñosa A and Prat-Bartomeu J.
DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1
Heliyon . 10(8): . Nº de cites: 1
